Oculis Holding AG (OCS) Other Operating Expenses (2022 - 2026)

Oculis Holding AG (OCS) recorded quarterly Other Operating Expenses of -$196658.7 in Q1 2026, up 0.52% quarter-over-quarter from -$197684.8 in Q4 2025, and down 43.75% on a YoY basis from -$349610.6 in Q1 2025.

Oculis Holding AG (OCS) Other Operating Expenses (2022 - 2026) Analysis & Trends

Oculis Holding AG's Other Operating Expenses history runs 5 years deep, the most recent figure standing at -$196658.7 for Q1 2026.

  • In Q1 2026, Other Operating Expenses fell 43.75% year-over-year to -$196658.7; the TTM figure through Mar 2026 stood at -$720851.8 (down 39.89% YoY), while the FY2025 annual figure was -$683138.7, down 47.4% from the prior year.
  • Other Operating Expenses was -$196658.7 for Q1 2026 at Oculis Holding AG, up from -$197684.8 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of -$0.0 in Q3 2022 to a low of -$37.7 million in Q1 2023.
  • Historically, Other Operating Expenses has averaged -$2.8 million across 5 years, with a median of -$136649.2 in 2025.
  • The sharpest annual moves came in 2023 and 2024: Other Operating Expenses sank 8874168778730300.0% in 2023, then soared 99.78% in 2024.
  • A 5-year view of Other Operating Expenses shows it stood at -$0.0 in 2022, then sank by 4478804300991900.0% to -$83424.2 in 2023, then sank by 66.94% to -$139265.7 in 2024, then plunged by 41.95% to -$197684.8 in 2025, then increased by 0.52% to -$196658.7 in 2026.
  • The last three Other Operating Expenses figures came in at -$196658.7 (Q1 2026), -$197684.8 (Q4 2025), and -$190016.6 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn -
7 Psyence Biomedical 229.39 Bn 229.38 Bn -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn
9 Abivax 90.15 Bn 90.15 Bn -
10 Oculis Holding AG 8.23 Bn 7.92 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -196,658.72
Dec 31, 2025 -197,684.83
Sep 30, 2025 -190,016.65
Jun 30, 2025 -136,491.60
Mar 31, 2025 -136,806.82
Dec 31, 2024 -139,265.67
Sep 30, 2024 -140,813.28
Jun 30, 2024 -98,415.62
Mar 31, 2024 -83,634.81
Dec 31, 2023 -83,424.23
Sep 30, 2023 -82,647.14
Mar 31, 2023 -37.69 Mn
Dec 31, 2022 0.00
Sep 30, 2022 0.00